Zobrazeno 1 - 10
of 43
pro vyhledávání: '"CL Dávila-Fajardo"'
Autor:
C Castaño-Amores, P Nieto-Gómez, S Portillo-Haro, MT Nieto, X Díaz-Villamarín, CL Dávila-Fajardo
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
M Hayon Ponce, X Diaz Villamarin, Ás Raquel, CL Dávila Fajardo, P Nieto Gómez, D Blanquez Martinez, I Casas Hidalgo
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Purpose The aim of this study was to evaluate the real-world efficacy and safety of adding Liraglutide in inadequately controlled patients with oral antidiabetic drugs. Material and methods This observational study assessed the efficacy an
Autor:
Ás Raquel, C García Fernández, CL Dávila Fajardo, P Nieto Gómez, M Hayon Ponce, D Blanquez Martinez, X Diaz Villamarin
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Low vitamin D levels have been postulated to be associated with insulin resistance, suggesting that vitamin D plays a role in glucose metabolism and homeostasis. Purpose To determine the prevalence of suboptimal vitamin D status in obese p
Autor:
A Caballero Romero, A Rodriguez Delgado, R Álvarez Sánchez, CL Dávila Fajardo, P Moreno Raya, P Nieto Gómez, D Blanquez Martinez, M Hayon Ponce, X Diaz Villamarin
Publikováno v:
Eur J Hosp Pharm
Background Cross-sex hormone therapy (CHT) is known to lead to alterations in the cardiovascular risk factor (CVRF). Purpose To assess changes in lipid profile and other CVRF in transsexual participants receiving CHT. Material and methods Retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::834e4663d16820d050853fea2e8367eb
https://europepmc.org/articles/PMC7535396/
https://europepmc.org/articles/PMC7535396/
Autor:
C Gómez-Peña, C García Fernández, M Valle Corpas, R Morón Romero, J Cabeza-Barrera, Mdc Gonzalez Medina, CL Dávila Fajardo, X Díaz-Villamarín, I Casas Hidalgo, Clara Marin
Publikováno v:
European Journal of Hospital Pharmacy. 23:A30.2-A31
Background Fampridine has been approved for improvement in walking capacity (WC) in multiple sclerosis adult patients with Expanded Disability Status Scale (EDSS) score of 4–7. Purpose To evaluate the effectiveness of fampridine in WC in MS patient
Autor:
R Morón Romero, LJ Martinez, CL Dávila Fajardo, X Diaz Villamarin, M Valle Corpas, D Blanquez Martinez, MJ Soto Pino, J Cabeza Barrera, E Raya Alvarez, Mdc Gonzalez Medina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A142.1-A142
Background Tocilizumab (TCZ) is a humanised monoclonal antibody inhibitor of interleukin 6 receptor, indicated in combination with methotrexate in the treatment of rheumatoid arthritis (RA) in patients with inadequate response or intolerance to prior
Autor:
P Toledo Frías, F Burillo Gómez, A Bautista Pavés, C Correa Vilches, JG Sanchez Ramos, X Diaz Villamarin, S Martinez Huertas, LJ Martinez Gonzalez, J Cabeza Barrera, CL Dávila Fajardo
Publikováno v:
European Journal of Hospital Pharmacy. 23:A188.1-A188
Background Clopidogrel provides a reduction in cardiovascular events in acute coronary syndrome (ACS) patients, particularly for those who have undergone percutaneous coronary intervention (PCI). The cardiovascular response has been associated with s
Autor:
JG Sanchez Ramos, X Diaz Villamarin, LJ Martinez Gonzalez, Mdc Marin, S Martinez Huertas, Francisco V. Fernández, J Cabeza Barrera, CL Dávila Fajardo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A132.1-A132
Background Clopidogrel is metabolised by CYP2C19 to the active metabolite responsible for the inhibition of platelet aggregation. The P-glycoprotein encoded by the ABCB1 gene is key in drug absorption. The effects differ according to genotype ABCB1 a
Autor:
R Morón Romero, MC González Medina, M. Marín, CL Dávila Fajardo, J Cabeza Barrera, X Diaz Villamarin
Publikováno v:
European Journal of Hospital Pharmacy. 22:A6.2-A6
Background A prospective study in which the standard parenteral nutrition prescribed by physicians for adult patients was compared with that designed by a resident pharmacist taking advantage of nutritional knowledge acquired during an internship in
Autor:
A Caballero Romero, CL Dávila Fajardo, D Blanquez Martinez, C Gonzalez Medina, R Morón Romero
Publikováno v:
European Journal of Hospital Pharmacy. 21:A19.1-A19
Background Hyperkalaemia is an elevated serum potassium level above 5.5 mmol/L. It can be due to an increased intake, redistribution or decreased renal excretion of potassium. Very high levels of potassium are a medical emergency because of the risk